Epilepsy diagnosis: Positron emission tomography

Handbook of Clinical Neurology

Volumn 107, Issue , 2012, Pages 409-424

  Kumar, Ajay ^a   Semah, Franck ^b   Chugani, Harry T ^a   Theodore, William H ^c  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865592845     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52898-8.00026-4     Document Type: Chapter

References (185)

1. Arnold S., Schlaug G., Niemann H., et al. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology 1996, 46:1422-1430.
2. Arnold S., Berthele A., Drzezga A., et al. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia. Epilepsia 2000, 41:818-824.
3. Asano E., Chugani D.C., Muzik O., et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 2000, 54:1976-1984.
4. Asano E., Chugani D.C., Muzik O., et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 2001, 57:1269-1277.
5. Asano E., Juhasz C., Shah A., et al. Origin and propagation of epileptic spasms delineated on electrocorticography. Epilepsia 2005, 46:1086-1097.
6. Banati R.B., Goerres G.W., Myers R., et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
7. Bartenstein P.A., Duncan J.S., Prevett M.C., et al. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry 1993, 56:1295-1302.
8. Bartenstein P.A., Prevett M.C., Duncan J.S., et al. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Res 1994, 18:119-125.
9. Batista C.E., Juhasz C., Muzik O., et al. Increased visual cortex glucose metabolism contralateral to angioma in children with Sturge-Weber syndrome. Dev Med Child Neurol 2007, 49:567-573.
10. Behen M.E., Juhász C., Helder E., et al. Cognitive function in Sturge-Weber syndrome: effect of side and extent of severe hypometabolism on PET scanning. Ann Neurol 2006, 60:S122. (Abstract).
11. Benedek K., Juhasz C., Chugani D.C., et al. Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol 2006, 21:26-31.
12. Bergström M., Kumlien E., Lilja A., et al. Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl - analysis of kinetic data. Acta Neurol Scand 1998, 98:224-231.
13. Biraben A., Semah F., Ribeiro M.J., et al. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 2004, 63:73-77.
14. Bouilleret V., Dupont S., Spelle L., et al. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol 2002, 51:202-208.
15. Bouilleret V., Semah F., Biraben A., et al. Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis. J Nucl Med 2005, 46:540-547.
16. Bouilleret V., Semah F., Chassoux F., et al. Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study. Neurology 2008, 70:177-184.
17. Bouvard S., Costes N., Bonnefoi F., et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain 2005, 128:1330-1343.
18. Carne R.P., O'Brien T.J., Kilpatrick C.J., et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain 2004, 127:2276-2285.
19. Chassoux F., Semah F., Bouilleret V., et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain 2004, 127:164-174.
20. Chugani H.T., Conti J.R. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 1996, 11:44-48.
21. Chugani H.T., Mazziotta J.C., Engel J., et al. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Ann Neurol 1987, 21:4-13.
22. Chugani H.T., Mazziotta J.C., Phelps M.E. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989, 114:244-253.
23. Chugani H.T., Shields W.D., Shewmon D.A., et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990, 27:406-413.
24. Chugani H.T., Shewmon D.A., Sankar R., et al. Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography. Ann Neurol 1992, 31:212-219.
25. Chugani H.T., Shewmon D.A., Khanna S., et al. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 1993, 9:10-15.
26. Chugani H.T., Shewmon D.A., Shields W.D., et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia 1993, 34:764-771.
27. Chugani H.T., Da Silva E., Chugani D.C. Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 1996, 39:643-649.
28. Chugani D.C., Muzik O., Chakraborty P., et al. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse 1998, 28:33-43.
29. Ciumas C., Wahlin T.B., Espino C., et al. The dopamine system in idiopathic generalized epilepsies: identification of syndrome-related changes. Neuroimage 2010, 51:606-615.
30. Curatolo P., Seri S., Verdecchia M., et al. Infantile spasms in tuberous sclerosis complex. Brain Dev 2001, 23:502-507.
31. da Silva E.A., Chugani D.C., Muzik O., et al. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 1997, 38:1198-1208.
32. de Jong B.M., van de Hoeven J.H., Pruim J., et al. Cortico-thalamic activation in generalized status epilepticus, a PET study. Clin Neurol Neurosurg 2008, 110:182-185.
33. Delbeke D., Lawrence S.K., Abou-Khalil B.W., et al. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol 1996, 31:261-266.
34. Depositario-Cabacar D.T., Riviello J.J., et al. Present status of surgical intervention for children with intractable seizures. Curr Neurol Neurosci Rep 2008, 8:123-129.
35. Didelot A., Ryvlin P., Lothe A., et al. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 2008, 131:2751-2764.
36. Drevets W.C., Thase M.E., Moses-Kolko E.L., et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 2007, 34:865-877.
37. Duchowny M., Jayakar P., Resnick T., et al. Epilepsy surgery in the first three years of life. Epilepsia 1998, 39:737-743.
38. Duncan J.S. Brain imaging in idiopathic generalized epilepsies. Epilepsia 2005, 46:108-111.
39. Dupont S., Semah F., Clemenceau S., et al. Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy: a study using positron emission tomography with 18fluorodeoxyglucose. Arch Neurol 2000, 57:1331-1336.
40. Dupont S., Croize A.C., Semah F., et al. Is amygdalohippocampectomy really selective in medial temporal lobe epilepsy? A study using positron emission tomography with (18)fluorodeoxyglucose. Epilepsia 2001, 42:731-740.
41. Eluvathingal T.J., Behen M.E., Chugani H.T., et al. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol 2006, 21:846-851.
42. Engel J., Kuhl D.E., Phelps M.E., et al. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 1982, 12:529-537.
43. Engel J., Kuhl D.E., Phelps M.E., et al. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982, 12:510-517.
44. Engel J., Kuhl D.E., Phelps M.E. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982, 218:64-66.
45. Engel J.J., Van Ness P.C., Rasmussen T.B., et al. Outcome with respect to epileptic seizures. Surgical Treatment of the Epilepsies 1993, 609-622. Raven, New York. 2nd edn. J.J. Engel (Ed.).
46. Fedi M., Reutens D.C., Andermann F., et al. α-[11C]-methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res 2003, 52:203-213.
47. Fedi M., Berkovic S.F., Marini C., et al. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage 2006, 32:995-1000.
48. Fedi M., Berkovic S.F., Scheffer I.E., et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2008, 71:795-798.
49. Ferrie C.D., Maisey M., Cox T., et al. Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Arch Dis Child 1996, 75:102-107.
50. Fogarasi A., Hegyi M., Neuwirth M., et al. Comparative evaluation of concomitant structural and functional neuroimages in Rasmussen's encephalitis. J Neuroimaging 2003, 13:339-345.
51. Frost J.J., Mayberg H.S., Fisher R.S., et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 1988, 23:231-237.
52. Gaillard W.D., Bhatia S., Bookheimer S.Y., et al. [18F]-FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995, 45:123-126.
53. Gaillard W.D., White S., Malow B., et al. [18F]-FDG-PET in children and adolescents with partial seizures: role in epilepsy surgery evaluation. Epilepsy Res 1995, 20:77-84.
54. Gaillard W.D., Kopylev L., Weinstein S., et al. Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology 2002, 58:717-722.
55. Gaillard W.D., Weinstein S., Conry J., et al. Prognosis of children with partial epilepsy: MRI and serial 18FDG-PET. Neurology 2007, 68:655-659.
56. Gaily E.K., Shewmon D.A., Chugani H.T., et al. Asymmetric and asynchronous infantile spasms. Epilepsia 1995, 36:873-882.
57. Giovacchini G., Toczek M.T., Bonwetsch R., et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 2005, 46:1128-1135.
58. Goerres G.W., Revesz T., Duncan J., et al. Imaging cerebral vasculitis in refractory epilepsy using [11C](R)-PK11195 positron emission tomography. AJR Am J Roentgenol 2001, 176:1016-1018.
59. Gur R.C., Sussman N.M., Alavi A., et al. Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Neurology 1982, 32:1191-1194.
60. Hajek M., Antonini A., Leenders K.L., et al. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 1993, 43:79-86.
61. Hammers A., Koepp M.J., Labbe C., et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001, 56:897-906.
62. Hammers A., Koepp M.J., Hurlemann R., et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002, 125:2257-2271.
63. Hammers A., Asselin M.C., Hinz R., et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain 2007, 130:1009-1016.
64. Hasler G., Bonwetsch R., Giovacchini G., et al. 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007, 62:1258-1264.
65. Henry T.R., Sutherling W.W., Engel J., et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991, 10:174-182.
66. Henry T.R., Frey K.A., Sackellares J.C., et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993, 43:1998-2006.
67. Henry T.R., Mazziotta J.C., Engel J. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol 1993, 50:582-589.
68. Honbolygo F., Csepe V., Fekeshazy A., et al. Converging evidences on language impairment in Landau-Kleffner syndrome revealed by behavioral and brain activity measures: a case study. Clin Neurophysiol 2006, 117:295-305.
69. Iinuma K., Yanai K., Yanagisawa T., et al. Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome. Pediatr Neurol 1987, 3:12-18.
70. Iinuma K., Yokoyama H., Otsuki T., et al. Histamine H1 receptors in complex partial seizures. Lancet 1993, 341:238.
71. Itomi K., Okumura A., Negoro T., et al. Prognostic value of positron emission tomography in cryptogenic West syndrome. Dev Med Child Neurol 2002, 44:107-111.
72. Juhasz C., Nagy F., Muzik O., et al. [11C]Flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 1999, 40:566-574.
73. Juhasz C., Chugani D.C., Muzik O., et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 2000, 55:825-835.
74. Juhasz C., Chugani D.C., Muzik O., et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001, 56:1650-1658.
75. Juhász C., Chugani D.C., Asano E., et al. Alpha[11C]methyl-L-tryptophan positron emission tomography scanning in 176 patients with intractable epilepsy. Ann Neurol 2002, S118. (Abstract).
76. Juhasz C., Chugani D.C., Muzik O., et al. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 2003, 60:960-968.
77. Juhasz C., Batista C.E., Chugani D.C., et al. Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome. Eur J Paediatr Neurol 2007, 11:277-284.
78. Juhasz C., Lai C., Behen M.E., et al. White matter volume as a major predictor of cognitive function in Sturge-Weber syndrome. Arch Neurol 2007, 64:1169-1174.
79. Kagawa K., Chugani D.C., Asano E., et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 2005, 20:429-438.
80. Khan N., Leenders K.L., Hajek M., et al. Thalamic glucose metabolism in temporal lobe epilepsy measured with 18F-FDG positron emission tomography (PET). Epilepsy Res 1997, 28:233-243.
81. Kim Y.K., Lee D.S., Lee S.K., et al. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002, 43:1167-1174.
82. Kim Y.K., Lee D.S., Lee S.K., et al. Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med 2003, 44:1006-1012.
83. Kim D.W., Lee S.K., Chu K., et al. Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia. Neurology 2009, 72:211-216.
84. Knowlton R.C., Laxer K.D., Ende G., et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 1997, 42:829-837.
85. Knowlton R.C., Elgavish R.A., Bartolucci A., et al. Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol 2008, 64:35-41.
86. Koepp M.J., Woermann F.G. Imaging structure and function in refractory focal epilepsy. Lancet Neurol 2005, 4:42-53.
87. Koepp M.J., Richardson M.P., Brooks D.J., et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996, 119:1677-1687.
88. Koepp M.J., Labbe C., Richardson M.P., et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997, 120:1865-1876.
89. Koepp M.J., Richardson M.P., Brooks D.J., et al. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet 1998, 352:952-955.
90. Koepp M.J., Hammers A., Labbe C., et al. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000, 54:332-339.
91. Kramer U., Sue W.C., Mikati M.A. Focal features in West syndrome indicating candidacy for surgery. Pediatr Neurol 1997, 16:213-217.
92. Kuhl D.E., Engel J., Phelps M.E., et al. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1978, 8:348-360.
93. Kumada T., Okazawa H., Yamauchi H., et al. Focal glucose hypermetabolism in interictal state of West syndrome. Pediatr Neurol 2006, 34:47-50.
94. Kumar A., Chugani H.T., Luat A., et al. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008, 38:439-442.
95. Kumlien E., Hilton-Brown P., Spannere B., et al. In vitro quantitative autoradiography of (3H)-L-deprenyl and (3H)-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 1992, 33:610-617.
96. Kumlien E., Hartvig P., Valind S., et al. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 1999, 40:30-37.
97. Kumlien E., Nilsson A., Hagberg G., et al. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand 2001, 103:360-366.
98. la Fougère C., Böning G., Bartmann H., et al. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage 2010, 49:1406-1415.
99. Lamusuo S., Pitkanen A., Jutila L., et al. [11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 2000, 54:2252-2260.
100. Lamusuo S., Jutila L., Ylinen A., et al. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol 2001, 58:933-939.
101. Landvogt C., Buchholz H.G., Bernedo V., et al. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy. Epilepsia 2010, 51:1699-1706.
102. Langer O., Bauer B., Hammers A., et al. Pharmacoresistance in epilepsy: a pilot PET study with the p-glycoprotein substrate R-[11C]verapamil. Epilepsia 2007, 48:1774-1784.
103. Lee J.S., Asano E., Muzik O., et al. Sturge-Weber syndrome: correlation between clinical course and [18F]-FDG PET findings. Neurology 2001, 57:189-195.
104. Lee J.S., Juhasz C., Kaddurah A.K., et al. Patterns of cerebral glucose metabolism in early and late stages of Rasmussen's syndrome. J Child Neurol 2001, 16:798-805.
105. Lee S.K., Lee S.Y., Kim K.K., et al. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 2005, 58:525-532.
106. Lee J.J., Lee S.K., Lee S.Y., et al. Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities. Seizure 2008, 17:514-523.
107. Leiderman D.B., Albert P., Balish M., et al. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F18. Arch Neurol 1994, 51:932-936.
108. Lerner J.T., Salamon N., Hauptman J.S., et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009, 50:1310-1335.
109. Liew C.J., Lim Y.M., Bonwetsch R., et al. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy. Epilepsia 2009, 50:234-239.
110. Lothe A., Didelot A., Hammers A., et al. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 2008, 131:2765-2782.
111. Luat A.F., Chugani H.T., Asano E., et al. Episodic receptive aphasia in a child with Landau-Kleffner syndrome: PET correlates. Brain Dev 2006, 28:592-596.
112. Luat A.F., Makki M., Chugani H.T. Neuroimaging in tuberous sclerosis complex. Curr Opin Neurol 2007, 20:142-150.
113. Madar I., Lesser R.P., Krauss G., et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 1997, 41:358-367.
114. Maeda N., Watanabe K., Negoro T., et al. Evolutional changes of cortical hypometabolism in West's syndrome. Lancet 1994, 343:1620-1623.
115. Manno E.M., Sperling M.R., Ding X., et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology 1994, 44:2331-2336.
116. Maquet P., Hirsch E., Dive D., et al. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia 1990, 31:778-783.
117. Mayberg H.S., Sadzot B., Meltzer C.C., et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 1991, 30:3-11.
118. Merlet I., Ostrowsky K., Costes N., et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 2004, 127:900-913.
119. Merlet I., Ryvlin P., Costes N., et al. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 2004, 22:886-896.
120. Meschaks A., Lindstrom P., Halldin C., et al. Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Arch Neurol 2005, 62:946-950.
121. Metz-Lutz M.N., Filippini M. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Epilepsia 2006, 47:71-75.
122. Miyauchi T., Nomura Y., Ohno S., et al. Positron emission tomography in three cases of Lennox-Gastaut syndrome. Jpn J Psychiatry Neurol 1988, 42:795-804.
123. Müller R.A., Chugani H.T., Muzik O., et al. Language and motor functions activate calcified hemisphere in patients with Sturge-Weber syndrome: a positron emission tomography study. J Child Neurol 1997, 12:431-437.
124. Muzik O., da Silva E.A., Juhasz C., et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000, 54:171-179.
125. Nagy F., Chugani D.C., Juhasz C., et al. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex. J Cereb Blood Flow Metab 1999, 19:939-947.
126. Natsume J., Watanabe K., Maeda N., et al. Cortical hypometabolism and delayed myelination in West syndrome. Epilepsia 1996, 37:1180-1184.
127. Natsume J., Kumakura Y., Bernasconi N., et al. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 2003, 60:756-761.
128. Nishida M., Asano E., Juhasz C., et al. Cortical glucose metabolism correlates negatively with delta-slowing and spike-frequency in epilepsy associated with tuberous sclerosis. Hum Brain Mapp 2008, 29:1255-1264.
129. O'Brien T.J., Hicks R.J., Ware R., et al. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy. J Nucl Med 2001, 42:1158-1165.
130. Ohta Y., Nariai T., Akimoto H., et al. Tuberous sclerosis: epileptogenicity and multimodal presurgical evaluations. Childs Nerv Syst 2001, 17:313-319.
131. Ollenberger G.P., Byrne A.J., Berlangieri S.U., et al. Assessment of the role of [18F]-FDG PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging 2005, 32:1311-1316.
132. Patil S., Biassoni L., Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med 2007, 37:357-381.
133. Pearl P.L., Gibson K.M., Quezado Z., et al. Decreased GABA-A binding on [11C]-FMZ-PET in succinic semialdehyde dehydrogenase (SSADH) deficiency. Neurology 2009, 73:423-429.
134. Pfund Z., Kagawa K., Juhász C., et al. Quantitative analysis of gray- and white-matter volumes and glucose metabolism in Sturge-Weber syndrome. J Child Neurol 2003, 18:119-126.
135. Phi J.H., Paeng J.C., Lee H.S., et al. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet. J Nucl Med 2010, 51:728-734.
136. Picard F., Bruel D., Servent D., et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 2006, 129:2047-2060.
137. Poduri A., Golja A., Takeoka M., et al. Focal cortical malformations can show asymmetrically higher uptake on interictal fluorine-18 fluorodeoxyglucose positron emission tomography (PET). J Child Neurol 2007, 22:232-237.
138. Prevett M.C., Duncan J.S., Jones T., et al. Demonstration of thalamic activation during typical absence seizures using H2(15)O and PET. Neurology 1995, 45:1396-1402.
139. Prevett M.C., Lammertsma A.A., Brooks D.J., et al. Benzodiazepine-GABAA receptor binding during absence seizures. Epilepsia 1995, 36:592-599.
140. Richardson M.P., Koepp M.J., Brooks D.J., et al. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998, 51:485-492.
141. Rintahaka P.J., Chugani H.T. Clinical role of positron emission tomography in children with tuberous sclerosis complex. J Child Neurol 1997, 12:42-52.
142. Rintahaka P.J., Chugani H.T., Messa C., et al. Hemimegalencephaly: evaluation with positron emission tomography. Pediatr Neurol 1993, 9:21-28.
143. Rintahaka P.J., Chugani H.T., Sankar R. Landau-Kleffner syndrome with continuous spikes and waves during slow-wave sleep. J Child Neurol 1995, 10:127-133.
144. Ryvlin P., Bouvard S., Le Bars D., et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998, 121:2067-2081.
145. Ryvlin P., Bouvard S., Le Bars D., et al. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 1999, 53:1882-1885.
146. Salanova V., Markand O., Worth R., et al. [18F]-FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome. Acta Neurol Scand 1998, 97:146-153.
147. Savic I., Ingvar M., Stone-Elander S. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993, 56:615-621.
148. Savic I., Pauli S., Thorell J.O., et al. In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry 1994, 57:797-804.
149. Savic I., Thorell J.O., Roland P. [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995, 36:1225-1232.
150. Savic I., Altshuler L., Baxter L. Pattern of interictal hypometabolism in PET scans with fludeoxyglucose F18 reflects prior seizure types in patients with mesial temporal lobe seizures. Arch Neurol 1997, 54:129-136.
151. Savic I., Lindstrom P., Gulyas B., et al. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62:1343-1351.
152. Semah F., Baulac M., Hasboun D., et al. Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation. Epilepsia 1995, 36:447-456.
153. Shiraishi H., Takano K., Shiga T., et al. Possible involvement of the tip of temporal lobe in Landau-Kleffner syndrome. Brain Dev 2007, 29:529-533.
154. Sperling M.R., Alavi A., Reivich M., et al. False lateralization of temporal lobe epilepsy with [18F]-FDG positron emission tomography. Epilepsia 1995, 36:722-727.
155. Swartz B.E., Halgren E., Delgado-Escueta A.V., et al. Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia 1989, 30:547-558.
156. Swartz B.W., Khonsari A., Vrown C., et al. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy. Epilepsia 1995, 36:388-395.
157. Swartz B.E., Brown C., Mandelkern M.A., et al. The use of 2-deoxy-2-[18F]fluoro-d-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol 2002, 4:245-252.
158. Szelies B., Herholz K., Heiss W.D., et al. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. J Comput Assist Tomogr 1983, 7:946-953.
159. Szelies B., Weber-Luxenburger G., Pawlik G., et al. MRI-guided flumazenil- and [18F]-FDG-PET in temporal lobe epilepsy. Neuroimage 1996, 3:109-118.
160. Szelies B., Sobesky J., Pawlik G., et al. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET. Eur J Neurol 2002, 9:137-142.
161. Takaya S., Mikuni N., Mitsueda T., et al. Improved cerebral function in mesial temporal lobe epilepsy after subtemporal amygdalohippocampectomy. Brain 2009, 132:185-194.
162. Theodore W.H., Newmark M.E., Sato S., et al. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol 1983, 14:429-437.
163. Theodore W.H., Brooks R., Margolin R., et al. Positron emission tomography in generalized seizures. Neurology 1985, 35:684-690.
164. Theodore W.H., Rose D., Patronas N., et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann Neurol 1987, 21:14-21.
165. Theodore W.H., Carson R.E., Andreasen P., et al. PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy. Epilepsy Res 1992, 13:129-139.
166. Theodore W.H., Sato S., Kufta C., et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992, 32:789-794.
167. Theodore W.H., Leiderman D., Gaillard W.D., et al. The effect of naloxone on cerebral blood flow and glucose metabolism in patients with complex partial seizures. Epilepsy Res 1993, 16:51-54.
168. Theodore W.H., Sato S., Kufta C.V., et al. [18F]-FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia 1997, 38:81-86.
169. Theodore W.H., Giovacchini G., Bonwetsch R., et al. The effect of antiepileptic drugs on 5-HT1A receptor binding measured by positron emission tomography. Epilepsia 2006, 47:499-503.
170. Theodore W.H., Hasler G., Giovacchini G., et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 2007, 48:1526-1530.
171. Toczek M.T., Carson R.E., Lang L., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003, 60:749-756.
172. Uijl S.G., Leijten F.S., Arends J.B., et al. The added value of [18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia 2007, 48:2121-2129.
173. Uijl S.G., Leijten F.S., Arends J.B., et al. Prognosis after temporal lobe epilepsy surgery: the value of combining predictors. Epilepsia 2008, 49:1317-1323.
174. Van Bogaert P., Massager N., Tugendhaft P., et al. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage 2000, 12:129-138.
175. Vinton A.B., Carne R., Hicks R.J., et al. The extent of resection of [18F]-FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain 2007, 130:548-560.
176. Wakamoto H., Chugani D.C., Juhasz C., et al. Alpha-methyl-l-tryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr Neurol 2008, 39:181-188.
177. Weitemeyer L., Kellinghaus C., Weckesser M., et al. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy. Epilepsia 2005, 46:1654-1660.
178. Werhahn K.J., Landvogt C., Klimpe S., et al. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia 2006, 47:1392-1396.
179. Willmann O., Wennberg R., May T., et al. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy: a meta-analysis. Seizure 2007, 16:509-520.
180. Wong C.H., Bleasel A., Wen L., et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia 2010, 51:1365-1373.
181. Wyllie E., Comair Y.G., Kotagal P., et al. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998, 44:740-748.
182. Yanai K., Iinuma K., Matsuzawa T., et al. Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography. Eur J Nucl Med 1987, 13:292-296.
183. You S.J., Lee J.K., Ko T.S. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia. Brain Dev 2007, 29:167-170.
184. Yun C.H., Lee S.K., Lee S.Y., et al. Prognostic factors in neocortical epilepsy surgery: multivariate analysis. Epilepsia 2006, 47:574-579.
185. Zimmer L., Mauger G., Le Bars D., et al. Effect of endogenous serotonin on the binding of the 5-HT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J Neurochem 2002, 80:278-286.